# LSP Dementia Fund

> LSP Dementia Fund is a VC fund backing Biotechnology, Health Care and Life Science. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Feb 2026
- Lead investor: 60%
- Last updated: Aug 2026
- Website: https://www.lspvc.com/funds/dementia.html

LSP Dementia Fund is a venture capital fund managed by Life Sciences Partners.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $39M–$39M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 60% |
| Health Care | 1 | 20% |
| Life Science | 1 | 20% |
| Therapeutics | 1 | 20% |
| Pharmaceutical | 1 | 20% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 20% |
| Series B | 1 | 20% |
| Post-IPO Equity | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Belgium | 1 | 20% |
| Ireland | 1 | 20% |
| United States | 1 | 20% |
| The Netherlands | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aerska | Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders. | $39M | Series A | Feb 09, 2026 |  |
| Aerska | Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders. | $39M | Series A | Feb 09, 2026 |  |
| QurAlis | QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS . | $88M | Series B | Mar 09, 2023 |  |
| New Amsterdam Pharma | NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases. | $235M | Post-IPO Equity | Nov 23, 2022 |  |
| Nobi | Nobi is a smart lamp that ensures help can be provided in a flash in the event of a fall. It recognizes a fall, and it will notify a family member, contacts, or a specialized emergency call center. The lamp will then connect to that person to reassure them that help is on the way. If necessary, it can even unlock the smart lock on the front door. | $14.5M | Venture - Series Unknown | Jan 28, 2022 |  |

5 of 5 investments shown.

## Co-investors
- [age1](https://shizune.co/investors/profile/age-1) — VC Fund, 2 deals together
- [Iaso Ventures](https://shizune.co/investors/profile/iaso-ventures) — VC Fund, 2 deals together
- [EQT Life Sciences](https://shizune.co/investors/profile/life-sciences-partners) — VC Fund, 2 deals together
- [Bain Capital Life Sciences](https://shizune.co/investors/profile/bain-capital-life-sciences) — VC Fund, 1 deal together
- [Mission BioCapital](https://shizune.co/investors/profile/bioinnovation-capital) — VC Fund, 1 deal together
- [BNP Paribas Fortis](https://shizune.co/investors/profile/bnp-paribas-fortis) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [Biotechnology VC Funds in Ireland](https://shizune.co/investors/biotechnology-vc-funds-ireland)
- [Biotech Investors in Ireland](https://shizune.co/investors/biotech-investors-ireland)
- [Biotech VC Funds in Ireland](https://shizune.co/investors/biotech-vc-funds-ireland)

## FAQ

### What does LSP Dementia Fund invest in?

LSP Dementia Fund invests primarily in Biotechnology, Health Care and Life Science startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is LSP Dementia Fund's check size?

LSP Dementia Fund typically joins rounds of $39M–$39M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LSP Dementia Fund participates in.

### When did LSP Dementia Fund last invest?

The most recent investment recorded for LSP Dementia Fund closed in Feb 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co